Cyclerion Therapeutics (CYCN) Depreciation & Amortization (CF) (2018 - 2022)

Cyclerion Therapeutics' Depreciation & Amortization (CF) history runs 5 years deep, the most recent figure standing at $100000.0 for Q3 2022.

• In Q3 2022, Depreciation & Amortization (CF) fell 83.33% year-over-year to $100000.0; the TTM figure through Jun 2023 stood at $100000.0 (down 87.44% YoY), while the FY2022 annual figure was $65000.0, down 86.23% from the prior year.
• Depreciation & Amortization (CF) for Q3 2022 stood at $100000.0, roughly flat from $100000.0 in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $800000.0 in Q2 2019, with the low at $48000.0 in Q4 2021.
• The 5-year median for Depreciation & Amortization (CF) is $466000.0 (2018), against an average of $413315.8.
• The sharpest annual moves came in 2019 and 2021: Depreciation & Amortization (CF) jumped 100.0% in 2019, then tumbled 89.85% in 2021.
• Cyclerion Therapeutics' Depreciation & Amortization (CF) stood at $466000.0 in 2018, then surged by 40.13% to $653000.0 in 2019, then declined by 27.57% to $473000.0 in 2020, then sank by 89.85% to $48000.0 in 2021, then jumped by 108.33% to $100000.0 in 2022.
• Business Quant data shows CYCN's Depreciation & Amortization (CF) at $100000.0 in Q3 2022, $100000.0 in Q2 2022, and $48000.0 in Q1 2022.